![Magnifying-Glass-Pills-Blue-Background](/web/20220602010912im_/https://labblog.uofmhealth.org/sites/lab/files/2022-05/Magnifying-Glass-Pills-Blue-Background.jpg)
Common prostate cancer medications may be less safe than previously thought
Men with advanced prostate cancer taking abiraterone or enzalutamide plus hormone therapy were at higher risk of serious medical issues than their peers undergoing hormone therapy alone.